In vivo, the pharmacological inhibition of RAGE halted insulin-induced tumor growth, without affecting blood glucose homeostasis [107] and RAGE-induced insulin resistance, a condition associated with aberrant IGF activation [110]. Here, INS is linked to neoplasm.